Status:
COMPLETED
Non Invasive Assessment of Liver Fibrosis in Fatty Liver Disease
Lead Sponsor:
Fundación Clínica Médica Sur
Conditions:
Non Alcoholic Fatty Liver Disease
Eligibility:
All Genders
18-69 years
Phase:
NA
Brief Summary
The purpose of this randomized clinical trial is to evaluate the utility of noninvasive markers for the detection of advanced fibrosis in patients newly diagnosed with Non-alcoholic Fatty Liver Diseas...
Eligibility Criteria
Inclusion
- Patients with BMI ≥ 27 Kg/m2 and any stage of non alcoholic fatty liver, diagnosed by ultrasound.
Exclusion
- Patients with other liver disease.
- Patients under treatment with tamoxifen, methotrexate, amiodarone, diltiazem or other drugs able to induce fatty liver.
- Patients with alcohol consumption greater than 140 gr. per week
- Patients who have received blood transfusion before 1990
Key Trial Info
Start Date :
July 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2016
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT01874249
Start Date
July 1 2012
End Date
August 1 2016
Last Update
August 9 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medica Sur Clinic & Foundation
Mexico City, Mexico City, Mexico, 14050